Cryomass Technologies CRYM · USD

Its shares trade under the ticker CRYM. It has been listed since 26 November 2013. In the fiscal year to 31 December 2022, it reported a net loss of $10.4m. At that date it held total assets of $7.9m and shareholders' equity of $4.6m.

CryoMass Technologies, Inc. engages in the operation of medical marijuana dispensaries and related businesses. The company is headquartered in Denver, Colorado. The company went IPO on 2013-11-26. The firm owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The firm through its CryoMass patented liquid nitrogen has built a Trichome Separation unit. The Trichome Separation system is optimized for the capture of fully intact cannabis and hemp trichomes, as well as terpenes. The company can be used within minutes after plants have been cut and can also efficiently capture trichomes from fresh frozen or even dried plant parts, including trim. The CryoMass system, on the other hand, stabilizes and collects fully intact trichomes at harvest, leaving no opportunity for such wasteful loss.

Figures and description from our data supplier, not checked against the company's own report.

• Dr. Delon HumanIndependent Chairman of the Board$87,530
• Mr. Christian NoelChief Executive Officer, Director, since 2021$681,940
• Mr. Philip MullinChief Financial Officer$420,000
• Ms. Patricia KovacevicGeneral Counsel, Company Secretary, Head of External Affairs$319,440
• Mr. Mario GobboIndependent Director$50,510
• Mr. Simon LangelierIndependent Director$32,000
• Mr. Mark RadkeIndependent Director$50,510

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.